In 1990, Comite was awarded a second patent for the use of Clomifene to increase bone mass in premenopausal women.[5] Alongside her work in precision medicine and integrated medical analysis, she is also known for founding Women's Health at Yale in 1992.[6][7] Comite is known for her work in clinical hormone research, and as the founder of Women's Health at Yale in the early 1990s.
Field of study
Comite is known for having an integrated approach to health care delivery using precision medicine.[8][9] She has researched hormonal changes and aging, and in particular, issues of Hypogonadism (Low T) in men and how it impacts the onset of certain associated diseases such as type 2 diabetes and heart disease.[10]
Her research involves studying delivery systems and how they impact health outcomes; it has been her focus as a Senior Clinical and Research Adviser to the Offices of Alternative Medicine (OAM) at NIH.[11]
↑ Comite, Florence; Cutler, Gordon B.; Rivier, Jean; Vale, Wylie W.; Loriaux, D. Lynn; Crowley, William F. (December 24, 1981). "Short-Term Treatment of Idiopathic Precocious Puberty with a Long-Acting Analogue of Luteinizing Hormone-Releasing Hormone". New England Journal of Medicine. 305 (26): 1546–1550. doi:10.1056/NEJM198112243052602. PMID6458765.
↑ "New York Superdoctors"(PDF). Independent Doctors of New York: IDNY.org. May 19, 2013. Archived from the original(PDF) on April 7, 2014. Retrieved April 2, 2014.
This page is based on this Wikipedia article Text is available under the CC BY-SA 4.0 license; additional terms may apply. Images, videos and audio are available under their respective licenses.